Clinical implications for the use of a biomarker for subclinical rejection – Conflating arguments cause a disconnection between the premise and the conclusion

John Friedewald*, Michael Abecassis

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)2141-2142
Number of pages2
JournalAmerican Journal of Transplantation
Issue number7
StatePublished - Jul 2019


  • biomarker
  • kidney transplantation/nephrology
  • rejection: subclinical
  • translational research/science

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Cite this